Verduyn-van Weegen Felice Isabel's Form 4 filing
Evommune, Inc. (EVMN) · filed Nov 12, 2025
- Accession no.
- 0002094941-25-000004
- Filed
- Nov 12, 2025
- Trade date
- Nov 7, 2025
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 3 derivative transactions. Open-market purchases total $25.0M. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Verduyn-van Weegen Felice IsabelCIK 0002094941 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 7, 2025 | Common Stock | CConversionAcquired | +3,367,133 | – | – | 3,367,133 | Indirect | Duplicate filing |
| Nov 7, 2025 | Common Stock | PPurchaseAcquired | +1,562,500 | $16.00 | +$25,000,000 | 4,929,633 | Indirect | Duplicate filing |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 7, 2025 | Common Stock | CConversionDisposed | −1,947,477 | – | – | 0 | Indirect | Duplicate filing |
| Nov 7, 2025 | Common Stock | CConversionDisposed | −646,587 | – | – | 0 | Indirect | Duplicate filing |
| Nov 7, 2025 | Common Stock | CConversionDisposed | −773,069 | – | – | 0 | Indirect | Duplicate filing |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.